World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01474213
Date of registration: 31/10/2011
Primary sponsor: Shanghai 9th People's Hospital
Public title: Sedation Effect of Dexmedetomidine Versus Remifentanil to Fibreoptic Intubation
Scientific title: Dexmedetomidine Versus Remifentanil Target Controlled Infusion for Sedation During Awake Fibreoptic Nasotracheal Intubation
Date of first enrolment: November 2011
Target sample size: 40
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01474213
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care  
Countries of recruitment
China
Contacts
Name:   Hong Jiang, MD, PHD
Address: 
Telephone:
Email:
Affiliation:  Anesthesiology Department, Shanghai Ninth People's Hospital Affiliated Shanghai JiaoTong University School of Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- ASA grade I-III adult patients with difficult airway, who were undergoing elective
oral maxillofacial surgery

Exclusion Criteria:

- pregnant or lactating female,

- long-term opioids or sedative medication,

- patients < 18 years of age,

- severe bradycardia (HR < 50 beats/min),

- hypotension (systolic pressure < 90mmHg),

- any type of atrioventricular block on the ECG



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Intubation; Difficult
Intervention(s)
Drug: dexmedetomidine group
Drug: remifentanil group
Primary Outcome(s)
Patient's reaction to procedure [Time Frame: the duration of intubation, an expected average of 10 minutes]
Secondary Outcome(s)
Cardiac rhythm [Time Frame: 15 minutes before intubation and duration of intubation]
continuous ECG [Time Frame: 15 minutes before intubation and duration of intubation]
End tidal carbon dioxide [Time Frame: 15 minutes before intubation and duration of intubation]
HR [Time Frame: 15 minutes before intubation and duration of intubation]
NIBP [Time Frame: 15 minutes before intubation, duration of intubation]
Oxygen Saturation [Time Frame: 15 minutes before intubation and duration of intubation]
post operative visit [Time Frame: 24 hours]
RR [Time Frame: 15 minutes before intubation and duration of intubation]
Secondary ID(s)
JYMZK-002
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history